Y C Zheng,J J Peng
Y C Zheng
Colorectal cancer(CRC) ranks among the most prevalent malignancies globally. In China, it ranked second in incidence and fourth in mortality among all malignant tumors in 2022. Although first- and second-line treatments have become increasi...
[Progress in the evaluation of tumor response status after neoadjuvant therapy for rectal cancer] [0.03%]
[术前新辅助治疗直肠癌疗效评价进展]
X Song,J G Han
X Song
In recent years,neoadjuvant therapy has become an integral part of the standard treatment for locally advanced rectal cancer.However,only approximately 15%-25% of patients achieve pathological complete response(pCR).With advances in tumor i...
[Current status and advances in the management of rectal anastomotic stenosis] [0.03%]
[直肠吻合口狭窄的研究进展与处理策略]
L Huang,L Kang
L Huang
Anastomotic leakage and anastomotic stenosis are among the most severe complications of rectal resection, among patients receiving neoadjuvant radiotherapy, the incidence of anastomotic stricture ranges from 3% to 6%. Anastomotic stricture ...
[Interpretation of key points in expert consensus on clinical diagnosis and treatment of perianal and perirectal abscess (2025 edition)] [0.03%]
《2025版肛门直肠周围脓肿临床诊断与治疗专家共识要点解读》
H J Wang,D Wei
H J Wang
Perianal and perirectal abscess is a common anorectal disease. In clinical practice, there are still some controversies regarding its clinical diagnosis, selection of surgical procedures, postoperative management strategies, and the treatme...
[Multidisciplinary integrated treatment of locally advanced and recurrent rectal cancer] [0.03%]
[局部晚期和复发性直肠癌的多学科综合治疗]
S R Liu,Y M Liu,X Chen et al.
S R Liu et al.
The treatment of locally advanced (LARC) and locally recurrent (LRRC) rectal cancers poses significant challenges due to the anatomical complexity and the aggressive nature of tumor invasion. The adoption of multidisciplinary team (MDT) tre...
[Conversion hepatectomy achieving pathological complete response in metachronous colorectal liver metastases: a multidisciplinary comprehensive treatment case report] [0.03%]
同期 Conversion 切除术联合多学科综合治疗在肠癌伴肝转移中的应用效果报道１例
Z Xiao,B T Li,S Z Zhang et al.
Z Xiao et al.
[Tumor regression grade for prognosis of patients with colorectal cancer liver metastasis undergoing conversion therapy] [0.03%]
[肿瘤消退分级在结直肠癌肝转移转化治疗患者中的预后价值]
Q Y Tian,X H Yang,H L Liu et al.
Q Y Tian et al.
Objective: To explore the prognostic significance of tumor regression grade (TRG) for patients with colorectal liver metastasis (CRLM) who underwent liver resection after conversion therapy. Methods: A retrospective cohort of 156 CRLM patie...
[A comparative study on early incision adaptability between symmetric and right-sided three-port laparoscopic bariatric surgery] [0.03%]
[腹腔镜减肥手术早期切口适应性对照研究]
J Liu,S L Wang,M J Guo et al.
J Liu et al.
Objective: To compare early postoperative incision outcomes between patients undergoing laparoscopic bariatric surgery with right-sided three-port versus symmetric three-port placement. Methods: A multicenter retrospective cohort study was ...
[Application of ultrasound-guided perianal sphincter injection of botulinum toxin A in sphincter-preserving surgery for male ultra-low rectal cancer under 3D laparoscopy] [0.03%]
三维腹腔镜下直肠男男性超低位保肛手术中应用肉毒杆菌毒素A经肛门括约肌内注射的临床研究
W Zheng,M Z Li,Q W Fan et al.
W Zheng et al.
Objective: To investigate the safety and preliminary efficacy of ultrasound-guided perianal sphincter injection of botulinum toxin type A (BTX-A) in sphincter-preserving surgery in male patients with ultra-low rectal cancer. Methods: A desc...
[Ex vivo liver resection with autotransplantation for initially unresectable colorectal liver metastases: a systematic review] [0.03%]
无手术指征的结肠癌肝转移患者行肝切除自体移植术治疗的系统评价
Z Z Gao,B Zhou,G G Li et al.
Z Z Gao et al.
Objective: To investigate the feasibility and efficacy of ex vivo liver resection and autologous liver transplantation (ERAT) in the treatment of initially unresectable colorectal cancer liver metastases (CRLM). Methods: Four databases, inc...